Injection Device Suppliers Introducing New Designs at a Record Pace

(Amherst, NH) – The proliferation of syringes and injectors for administering injectable drugs is occurring at a rate that is unprecedented in the history of the pharmaceutical market sector. There are currently more than ninety branded syringes and injectors in the global commercial marketplace, with new devices being introduced monthly.

The growing importance of therapeutic drugs that are developed for administration via injection is fostering an evolving ecosystem of designers, component suppliers, technologists, device producers, packagers and consultants that are defining the state-of-the-art for current and future injectable drug delivery. This evolution is producing new and enhanced syringes and injectors that are entering the commercial market at a rapid rate. This changing landscape represents a continual challenge to product developers, planners and marketers who must be aware of the opportunities this environment offers their own product candidates, as well as the adoption rate of new technology by competing market participants.

The evolving market for injectable drugs and the injection devices that deliver them is captured in a new and comprehensive publication researched and written by Greystone Research Associates. The 2016 Drug Injection Fact Book analyzes the global market for syringes and injectors and examines the drug therapeutics, market factors and supply chain alliances behind the evolution in drug injection. The Fact Book is designed to provide an encyclopedic level of information and data on this market segment, allowing readers to make choices and decisions with confidence. The Fact Book also assesses key therapeutic market segments, analyzes demand drivers, development factors and market considerations, and provides profiles of market sector participants.

More information is available at http://www.greystoneassociates.org

Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org

This release was published on openPR.